Financials
- Fiscal year
- 2025
- Total assets
- €53,513
- Profit
- €29,775
- Solvency
- 55.6%
ONCOLOGIX
ActiveSummary
ONCOLOGIX has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €29,776 and a net result of €29,775. Its solvency ranks better than 45% of 608 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Activity
Other research and development on natural sciences
NACE 72109
1 site
Size
€53,513total assets 2025
- Equity
- €29,776
- Profit
- €29,775
Turnover not published (abridged schema)
Structure
Accounts filed 28 d late0 of 1 deed read
Why 90- Size: total assets €53,513- Founded in 2025+ Sector Scientific research and development (NACE 72)+ Liquidity: current ratio 2.04, cash €11,941Show the evidence
Checked score
Score 2025
90
/ 100
Excellent
Probability in this band: under 0.55%
Better than 61% of its sector peers (NACE 72, micro)
Performance against the sector, not lower risk
Financial strength
Strong
Solvency
81
equity 55.6% of total assets
Liquidity
56
short-term debt 44.4% · cash 22.3%
Profitability
100
return on assets 55.6%
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
- Sector Scientific research and development (NACE 72) lowers the probability
- Liquidity: current ratio 2.04, cash €11,941 lowers the probability
- Size: total assets €53,513 raises the probability for this profile
- Founded in 2025 raises the probability for this profile
Credit up to €2,500 at 30 days acceptable
Liquidity ample (current ratio 2.04; short-term debt: 44.4% and cash: 22.3% of total assets), and 44.4% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 72, micro). Better than this share of them on solvency 49%, liquidity 44%, profitability 90%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 05-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filingDeviation from the deadline
2025
28 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
- Annual accounts filedfiscal year 2025 · micro…
Key points
By topic
Timeline
- Events
- 1
- Since
- 2026
- 28-08-2026Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Other research and development on natural sciencesNACE 72109
- Founded
- 19-09-2025
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.